Global Infection and Infection POCT Testing Market Growth (Status and Outlook) 2024-2030

Global Infection and Infection POCT Testing Market Growth (Status and Outlook) 2024-2030

Infectious and infectious POCT (Point-of-Care Testing) tests are rapid diagnostic tests performed at the point of patient care. POCT testing devices and kits are designed to provide test results quickly without the need for complex laboratory facilities, usually within minutes to hours. This is critical for rapid diagnosis and timely treatment of infectious diseases and infections.

The global Infection and Infection POCT Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Infection and Infection POCT Testing Industry Forecast” looks at past sales and reviews total world Infection and Infection POCT Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Infection and Infection POCT Testing sales for 2023 through 2029. With Infection and Infection POCT Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infection and Infection POCT Testing industry.

This Insight Report provides a comprehensive analysis of the global Infection and Infection POCT Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infection and Infection POCT Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infection and Infection POCT Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infection and Infection POCT Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infection and Infection POCT Testing.

United States market for Infection and Infection POCT Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Infection and Infection POCT Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Infection and Infection POCT Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Infection and Infection POCT Testing players cover SERION Immunologics, SD BIOSENSOR, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Infection and Infection POCT Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Equipment
Test Kit
Other

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Equipment
Test Kit
Other

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SERION Immunologics
SD BIOSENSOR
Bio-Rad Laboratories
Thermo Fisher Scientific
Abbott Laboratories
Roche Diagnostics
BioMerieux
PerkinElmer
Enzo Life Sciences
Abcam
DRG International
Creative Diagnostics
Beyotime
GenScript
Kehua Biotech
Mindray Medical
Antu Biotech
BD
Siemens
Qiagen

Please note: The report will take approximately 2 business days to prepare and deliver.